Back to Peptide Pedia
Cognitive & Nootropic
Emerging Research

Adamax

ADMX

Experimental nootropic peptide.

Also known as: N-Acetyl Semax Amidate analog

Research dose range100–300 mcg daily (research models)
Route studiedIntranasal / subcutaneous
Study durationDaily, multi-week studies
Storage2–8 °C reconstituted

Overview

Adamax is an experimental nootropic peptide studied in cognition and neurotrophic research, related to the Semax family of ACTH-derived peptides.

Key research findings

A highly experimental stabilized analog in the Semax family, terminal-modified to resist enzymatic breakdown for stronger, longer-lasting nootropic and BDNF-related effects. Among the more speculative cognitive entries, with very little dedicated published data.

Mechanism of action

Studied for modulating BDNF and neurotrophic signaling similar to the Semax peptide family, with experimental structural modifications.

Molecular information

Weight~854 Da
Length7 amino acids (modified)
TypeExperimental Semax-family analog

Terminal modifications are proposed to increase stability and duration versus standard Semax.

Pharmacokinetics

Peak: ~0.25 hoursHalf-life: ~Longer than Semax (estimated)Cleared: ~24 hours
Peak · 1hHalf-life · 4h

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

  • Cognitive-enhancement research
  • Neurotrophic-signaling studies
  • Experimental nootropic investigations

Research protocols

Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.

Conservative referenceAmount: 100 mcgFrequency: 1–2× dailyRoute: Intranasal
Standard referenceAmount: 300 mcgFrequency: Daily (divided)Route: Intranasal

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Acute

    Focus and alertness changes reported anecdotally, with longer duration than Semax.

  2. Week 1–4

    BDNF-mediated cognitive effects proposed; dedicated data are limited.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

NA-Semax Amidate

Overlapping stabilized Semax analog.

Avoid combination

Semax

Same peptide family — redundant activity.

Avoid combination

Adalank

Focus plus calm pairing of stabilized analogs.

Compatible

How to reconstitute

Important

Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Many protocols prepare a metered intranasal spray.

  1. 1Allow the vial to reach room temperature (15–20 minutes).
  2. 2Swab the stopper with alcohol and let it air dry.
  3. 3Add bacteriostatic water slowly down the vial wall.
  4. 4Swirl gently until dissolved into a clear solution.
  5. 5Refrigerate at 2–8 °C and protect from light.
Open reconstitution calculator

Quality indicators

Uniform white powder

Lyophilized cake should be white to off-white without discoloration.

Clear solution

Reconstitutes to a clear, colorless, particle-free solution.

Cold-chain integrity

Reconstituted solution requires 2–8 °C storage.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • One of the more experimental entries — published characterization is sparse.
  • Nasal irritation is the most commonly reported intranasal signal for this peptide family.

References & further reading

Semax analogs and BDNF-mediated cognition (review)

Preclinicalexperimental analogBDNF

Review of the Semax family and its stabilized analogs and their proposed BDNF-related cognitive effects.

View study

Topics

nootropicexperimentalbdnf

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Emerging Research

Active but early-stage research; evidence still developing.

Quick reference
Dose range100–300 mcg daily (research models)
RouteIntranasal / subcutaneous
DurationDaily, multi-week studies
Storage2–8 °C reconstituted
Half-life~Longer than Semax (estimated)
Catalogue status

This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.

Browse catalogue